Bret Christensen

Bret Christensen

Chairman at
Axena Health, Inc.

Net worth: 75 190 $ as of 2026-05-30

55 year
Health Technology
Consumer Services
Health Services

Profile

Bret Christensen is currently Chairman at Axena Health, Inc. since 2024.
Mr. Christensen is also a Director at Insulet International Holdings Ltd. and a Director at Insulet International Ltd. since 2019.
Former roles include Chief Executive Officer & Director at BioTE Medical LLC, President, Chief Executive Officer & Director at DermTech, Inc. from 2023 to 2024, Chief Executive Officer & Director at biote Corp.
from 2025 to 2026, Vice President-Sales & Marketing at Hologic, Inc. from 2009 to 2013, General Manager-Preventive Care at Myriad Genetics, Inc. from 2013 to 2017, and Chief Commercial Officer & Executive VP at Insulet Corp.
from 2019 to 2023.
Education includes an MBA from David Eccles School of Business and an undergraduate degree from Utah Valley University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-07 37,595 ( 0.12% ) 75 190 $ 2026-05-30

Bret Christensen active positions

CompaniesPositionStart
Director/Board Member 2019-04-11
Director/Board Member -
Chairman 2024-09-30

Former positions of Bret Christensen

CompaniesPositionEnd
BIOTE CORP. Chief Executive Officer 2026-06-11
Chief Executive Officer 2026-06-07
DERMTECH Chief Executive Officer 2024-08-31
INSULET CORPORATION Corporate Officer/Principal 2023-05-04
MYRIAD GENETICS, INC. Corporate Officer/Principal 2017-04-30
See the detail of Bret Christensen's experience

Training of Bret Christensen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

59

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Finance

Health Technology

Health Technology

Health Services

Health Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Bret Christensen